MULTIDOMAIN SYMPTOM FEATURES IN A PANS/PANDAS-LIKE PE-DIATRIC SUBGROUP WITH RECENT STREPTOCOCCAL EXPOSURE

Authors

  • Cristina-Gabriela SCHIOPU Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania
  • Alexandra BOLOS Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania
  • Oriana-Maria ONICESCU Alexandru Ioan Cuza University of Iasi
  • Carmen Gabriela LUPUSORU Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania
  • C. STEFANESCU Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania

DOI:

https://doi.org/10.22551/MSJ.2026.03.07

Keywords:

PANS, PANDAS, PEDIATRIC PSYCHIATRY, NEURO-INFLAMMATION, GROUP A STREPTOCOCCUS

Abstract

Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) describe debated pediatric neuropsychiatric presentations in which immune-mediated neuroinflammatory mechanisms have been proposed in at least a subset of cases. PANDAS is temporally linked to streptococcal infection, whereas Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) is broader and may follow infectious or non-infectious triggers. Materials and methods: This secondary exploratory study described Pediatric Acute-onset Neuropsychiatric Syndrome 31-Item Symptom Rating Scale (PANS-31) item-level findings in a pediatric psychiatric cohort. The source cohort included 96 children and adolescents evaluated through inpatient or outpatient child psychiatric services for neuropsychiatric symptoms and caregiver- or record-supported history suggestive of previous streptococcal exposure. Results: For the present descriptive comparison, 36 children simultaneously had antistreptolysin O (ASO) >200 IU/mL, reported <6-month streptococcal infection and abrupt symptoms onset or worsening; the remaining 60 participants formed the comparison group. Individual PANS-31 item scores were compared using Mann–Whitney U tests, rank-biserial effect sizes and Benjamini–Hochberg false discovery rate correction. Conclusions: Children meeting the three criteria showed higher scores for selected symptoms, especially dysgraphia/writing deterioration, motor tics, enuresis, cognitive/memory deficit, school-performance decline and affective/anxiety-related symptoms. These findings support a careful symptom-by-symptom description in suspected post-streptococcal neuropsychiatric presentations, without defining a diagnostic subtype or a new clinical score.

Author Biographies

  • Cristina-Gabriela SCHIOPU, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania

    Socola Institute of Psychiatry, Iasi

  • Alexandra BOLOS, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania

    Socola Institute of Psychiatry, Iasi 

  • Carmen Gabriela LUPUSORU, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania

    Socola Institute of Psychiatry, Iasi 

  • C. STEFANESCU, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania

    Socola Institute of Psychiatry, Iasi 

References

1. Prato A, Gulisano M, Scerbo M, et al. Diagnostic approach to pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): A narrative review of literature data. Front Pediatr 2021; 9: 746639.

2. Vreeland A, Thienemann M, Frankovich J. A narrative review: Is pediatric acute-onset neuropsychiatric syndrome (PANS) a syndrome? Dev Neurosci 2023; 45: 263-278.

3. La Bella S, Scorrano G, Rinaldi M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): Myth or reality? The state of the art on a controversial disease. Microorganisms 2023; 11: 2549.

4. Grandinetti R, Mussi N, Pilloni S, et al. Pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections: A Delphi study and consensus document about definition, diagnostic criteria, treatment and follow-up. Front Immunol 2024; 15: 1420663.

5. Łojek P, Rzeszutek M. PANS and PANDAS–symptoms beyond OCD and tics–a systematic review. J Psychiatr Res 2025; 187: 144-153.

6. Bernstein GA, Khan MH, Freese RL, et al. Psychometric properties of the PANS 31-item symptom rating scale. J Child Adolesc Psychopharmacol 2024; 34: 157-162.

7. Pfeiffer HCV, Wickenhauser M, Woodhall M, et al. Pediatric acute-onset neuropsychiatric syndrome-PANS: Identification, clinical features and autoantibody findings. Acta Paediatr 2021; 110: 3153-3160.

8. Bottoms KB, Rice DN, Veerapandiyan A. Cognitive, behavioral, and psychiatric presentations of pediatric acute-onset neuropsychiatric syndrome. Front Behav Neurosci 2024; 18: 1467469.

9. Board of Directors, American Academy of Pediatrics. Pediatric acute-onset neuropsychiatric syndrome (PANS): Clinical report. Pediatrics 2025; 155: e2024070334.

10. Tagi VM, Quarta A, Bosetti A, et al. Nutritional assessment and dietary intervention in children with pediatric acute-onset neuropsychiatric syndrome (PANS). Front Nutr 2025; 11: 1477893.

11. Gagliano A, Maniaci M, Maugeri M, et al. PANS and gut microbiota: A narrative review. Int J Mol Sci 2025; 26: 7767.

12. Goren R, Bitnun A, Doja A, et al. Frequency and impact of pediatric acute-onset neuropsychiatric syndrome/pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections diagnosis in Canada. Pediatric Child Health 2025; 30: 157-163.

Additional Files

Published

2026-09-28

Issue

Section

INTERNAL MEDICINE - PEDIATRICS